Analyzing the price chart for GlaxoSmithKline (NYSE:GSK) has revealed a potential bearish inside day candle pattern. Yesterday's price range of $48.15 and $48.50 is within the prior day's high and low of the day. This trading action often signifies indecision by bulls and bears to drive prices higher or lower and often implies a possible change in trend. Owners of GlaxoSmithKline may want to consider a possible hedge in the event a pullback occurs. Look for confirmation in the next few trading days.
GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders
In the past 52 weeks, GlaxoSmithKline share prices have been bracketed by a low of $41.68 and a high of $48.55 and closed yesterday at $48.47, 16% above that low price. The 200-day and 50-day moving averages have moved 0.11% higher and 0.61% higher over the past week, respectively.
GlaxoSmithKline (NYSE:GSK) is currently priced 0.2% above its average consensus analyst price target of $48.39. The stock should find initial support at its 50-day moving average (MA) of $45.68 and further support at its 200-day MA of $45.26.